SLB @ 2018 ALAI/SMI announced

SLB Speakers @ 2018 ALAI/SMI announced

SLB is pleased to host yet another guest symposium. In 2018, SLB will host a session at the ALAI/SMI joint meeting in Cancun. Below are the featured speakers that have been selected from applications from the membership.  Another example of the many opportunities that SLB membership offers!

Dr. Christoph Scheiermann obtained his PhD at Imperial College London in 2008 under the supervision of Dr. Sussan Nourshargh working on the role that adhesion molecules play in leukocyte trafficking and the integrity of the neural myelin sheath. He combined immunology and neural aspects in postdoctoral work with Dr. Paul Frenette at the Mount Sinai School of Medicine and the Albert Einstein College of Medicine, New York, where he focused on a time-of-day-effect in the migration of immune cells. Since 2013 he is heading his own research group at the Ludwig-Maximilians-University Munich. His current work deals with circadian rhythms in the immune response

Patricia C. Fulkerson, MD, PhD, is an assistant professor in the Division of Allergy and Immunology at Cincinnati Children’s Hospital Medical Center. Dr. Fulkerson’s independent research program is focused on delineating the molecular program that orchestrates eosinophil development and functional responses. She has over 15 years of research experience working on eosinophil biology using both ex vivo functional assays and in vivo experimental models. Her overall aim is to identify novel therapeutic targets to block eosinophil production for the treatment of patients with eosinophilic disorders. In addition, Dr. Fulkerson’s clinical practice is focused on patients with eosinophil-associated disorders as a physician in the Cincinnati Center for Eosinophilic Disorders
Dr Helen McGettrick is a Senior Research Fellow (Associate Professor) in the Institute of Inflammation and Ageing in the Centre for Translational Inflammation Research at the University of Birmingham, UK. She completed her PhD in Medical Sciences 2006, followed by 3 postdoctoral research positions at the University of Birmingham. She was appointed as a University Fellow in Inflammation Biology in 2011, and a year later successfully won a five year Arthritis Research UK Career Development Fellowship. She was recently awarded the prestigious “Garrod Prizeby the British Society for Rheumatology in 2016. She is also an Honorary Lecturer at the University of Glasgow and Newcastle University (UK). Her research focuses on identifying the endogenous regulatory pathways that control the recruitment of the inflammatory infiltration during an acute inflammatory episode, and how these go wrong in immune mediated inflammatory diseases. Her team has two main areas of interest: (i) mesenchymal stromal cell (MSC) crosstalk with vascular endothelial cells and (ii) the adiponectin-PEPITEM axis in arthritis.
Dr. Caroline Jones is currently an Assistant Professor in the Department of Biological Sciences at Virginia Polytechnic Institute and State University. She completed her post-doctoral training at the Center for Engineering in Medicine at Harvard Medical School (PI - Daniel Irimia, M.D., Ph.D.) and Ph.D. in Biomedical Engineering from University of California, Davis (PI - Alexander Revzin, Ph.D).  The Jones Laboratory is currently focused on engineering innovative lab-on-a-chip platforms to model and study leukocyte-pathogen interactions with single cell precision. They are currently working on merging quantitative single-cell measurements and mathematical modeling with the goal of understanding how a patient's unique neutrophil migratory signature correlates to clinical outcome.